Division of Infection and Immunity is one of the world’s leading centres for teaching and research in immunology, pathogen evolution and host-pathogen interaction. We are working to achieve breakthroughs in some of the world’s biggest global health problems from COVID-19 to Cancer. Through understanding mechanisms of disease we aim to improve prevention, diagnosis, intervention and treatment.  

We have outstanding facilities, including the Institute of Immunity and Transplantation (IIT). The IIT is one of only a few centres in the world dedicated to collaborative immunity research, bringing together teams of more than 200 experts and more than 30,000 patients.  

Our "bench to bedside" approach means that our research teams take information discovered in the laboratory and use it to work with clinical colleagues - doctors, nurses and other healthcare professionals - to find new therapies for patients. This research-led approach enables us to develop new vaccines and to use cell and gene therapy to treat many serious immune-related diseases including cancer, HIV, and haemophilia. It also enables our clinical colleagues to improve the long-term outlook for transplant patients.